comparemela.com

Latest Breaking News On - டெக்சாஸ் இதய அரித்மியா நிறுவனம் இல் ஸ்டம்ப் - Page 5 : comparemela.com

TCAI leader participates in clinical trial for catheter that may prevent rare, life-threatening complication during cardiac ablation

Share this article Share this article AUSTIN, Texas, Feb. 12, 2021 /PRNewswire/ A physician with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David s Medical Center is among the first in the world to participate in a clinical trial to evaluate the safety and efficacy of a new cardiac-specific catheter used during pulsed field ablation (PFA), a new approach to treating patients with atrial fibrillation (A Fib). Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI, recently participated in the first-in-human trials of this catheter in Europe.

TCAI physicians participate in clinical trial for potential life-saving device for patients with heart rhythm disorders

Share this article Share this article AUSTIN, Texas, Feb. 5, 2021 /PRNewswire/ Physicians with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David s Medical Center are among the first in the world to participate in a clinical trial to evaluate a new esophageal protection device designed to make ablation procedures safer for patients with atrial fibrillation (A Fib), the most common type of cardiac arrhythmia. Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI, and Amin Al-Ahmad, M.D., cardiac electrophysiologist at TCAI, recently participated in the first-in-human trials in Europe.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.